
NORWAY – 3i acquires Active Pharmaceutical Ingredients for $395m
3i has backed the buyout of Active Pharmaceuticals Ingredients, an Oslo-based supplier and developer of pharmaceutical ingredients and division of NYSE-listed Alpharma Inc, for $395m.
Latest News
Bowmark bolsters investment team with two hires
Laura Clayfield and Raj Mukherji have joined the London-based mid-market sponsor
Capiton moves two assets to continuation vehicle; Fund V largely unrealised
Eurazeo and Unigestion among LPs in new fund for industrial tech businesses Raith and AEMtec
BlackRock mulls new vintage of private capital products for sophisticated retail investors in Europe
Global asset manager explores new generation of private market funds for wealthy individuals banking on positive uptake from retail investors
LDC outlines plans for new record year of deployment
Despite macro woes, sponsor wants to build up on last year’s pace of investment and exceed GBP 400m mark in 2023
Back to Top